Article

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review

Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
European Journal of Nuclear Medicine (Impact Factor: 5.22). 08/2011; 38(12):2269-81. DOI: 10.1007/s00259-011-1904-z
Source: PubMed

ABSTRACT The impact on patients' health of radiopharmaceuticals in nuclear medicine diagnostics has not until now been evaluated systematically in a European context. Therefore, as part of the EU-funded Project PEDDOSE.NET ( www.peddose.net ), we review and summarize the current knowledge on biokinetics and dosimetry of commonly used diagnostic radiopharmaceuticals.
A detailed literature search on published biokinetic and dosimetric data was performed mostly via PubMed ( www.ncbi.nlm.nih.gov/pubmed ). In principle the criteria for inclusion of data followed the EANM Dosimetry Committee guidance document on good clinical reporting.
Data on dosimetry and biokinetics can be difficult to find, are scattered in various journals and, especially in paediatric nuclear medicine, are very scarce. The data collection and calculation methods vary with respect to the time-points, bladder voiding, dose assessment after the last data point and the way the effective dose was calculated. In many studies the number of subjects included for obtaining biokinetic and dosimetry data was fewer than ten, and some of the biokinetic data were acquired more than 20 years ago.
It would be of interest to generate new data on biokinetics and dosimetry in diagnostic nuclear medicine using state-of-the-art equipment and more uniform dosimetry protocols. For easier public access to dosimetry data for diagnostic radiopharmaceuticals, a database containing these data should be created and maintained.

Download full-text

Full-text

Available from: Manuel Bardiès, Jul 17, 2015
0 Followers
 · 
217 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Im Gegensatz zur Positronenemissionstomographie/Computertomographie (PET/CT) sind die auf dem Markt angebotenen Single-photon-emission-computed-tomography/CT(SPECT/CT)-Systeme sehr heterogen. Auf der Seite der Gammakameras sind Zweikopfsysteme etabliert, die sich bei den verschiedenen Wettbewerbern nur unwesentlich unterscheiden. Hingegen reicht bei der CT-Komponente die Palette von der einfachen Niedrigdosisröntgenröhre über die flachdetektorbasierte Cone-beam-CT-Technologie bis hin zum Mehrzeilenspiral-CT. Die CT-Bilddaten werden dabei zum einen zur anatomischen Korrelation funktionell auffälliger Befunde verwendet, können aber auch für eine Schwächungskorrektur der SPECT-Daten herangezogen werden. Neben einer qualitativen Verbesserung der SPECT-Bilder eröffnet sich damit nunmehr die Möglichkeit der Quantifizierung der Radioaktivitätskonzentration. Moderne iterative Rekonstruktionsalgorithmen erlauben unter Verwendung der Dichteinformation aus den CT-Daten eine Streu- und Schwächungskorrektur der SPECT-Daten. Inwiefern sich die Sensitivität szintigraphischer Untersuchungen durch den Einsatz schwächungskorrigierter Ganzkörper-SPECT/CT-Aufnahmen erhöhen lässt, muss erst in entsprechenden Studien gezeigt werden. Da bei der SPECT/CT nicht das Auffinden zusätzlicher Radionuklidspeicherungen, sondern die morphologische und damit verbunden die artdiagnostische Zuordnung das primäre Ziel darstellt, sollte auf die Ausgewogenheit notwendiger morphologischer Information und erforderlicher zusätzlicher Strahlenexposition geachtet werden. Neben der SPECT-geführten CT sollten auch alle technischen Möglichkeiten der Dosisreduktion ausgeschöpft werden.
    Der Radiologe 07/2012; 52(7). DOI:10.1007/s00117-011-2268-x · 0.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This work aims at assessing the performance of a portable detection system, equipped with an NaI(Tl) scintillation detector for in vivo thyroid monitoring, which was properly calibrated using an anthropomorphic neck phantom. The anthropomorphic physical phantoms commonly used for the efficiency calibration of in vivo counters often present certain limitations regarding the geometry and the activity distribution. Therefore, the feasibility of these detection systems for in vivo monitoring should be assessed whenever possible. To accomplish this assessment, patients to whom (99m)Tc and (123)I marked radiopharmaceuticals have been administered in the framework of nuclear medicine diagnostic procedures were monitored. As the biokinetic models of the administered radiopharmaceuticals are known, the time-dependent activity functions in the critical organs after administration are easily quantified. The measured activities in the thyroid using the NaI(Tl) scintillation detector were compared with the estimated activities using the biokinetic models, in order to reach conclusion about the applicability of the portable scintillation counter for in vivo thyroid monitoring. The state-of-the-art Monte Carlo computer program PENELOPE and two voxel phantoms (male and female) were used to evaluate the overall uncertainties influencing the thyroid monitoring. A computational parametric study was performed to quantify the influence of several parameters in the activity quantification (neck-detector distance, thyroid shape, thyroid size and overlying tissue thickness), which allowed one to gain insight and to better understand the discrepancies between the calculated and measured activities.
    Radiation Protection Dosimetry 02/2012; 151(2):252-61. DOI:10.1093/rpd/ncs011 · 0.86 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In contrast to positron emission tomography/computed tomography (PET/CT), the currently available single photon emission computed tomography/computed tomography (SPECT/CT) systems are very heterogeneous. On the side of the gamma cameras, dual-head systems are established, which are not very different from one manufacturer to the other. For the CT component, there are low dose tubes on the one side and flat detector-based cone beam CT and multislice-CT on the other. The CT image data can be used for anatomic correlation of suspicious findings as well as for attenuation correction of SPECT data. Attenuation correction enables on the one hand enhancement of SPECT image quality and on the other hand quantification of the radioactivity concentration becomes possible. Modern iterative reconstruction algorithms allow scatter correction and attenuation correction of SPECT data using the density values from CT. It still has to be shown to what extent attenuation-corrected whole body SPECT/CT studies will be able to improve the sensitivity of scintigraphy studies. As SPECT/CT primarily aims at morphologic correlation and not detection of additional lesions, an attempt should be made to balance the necessary anatomic information and the additional radiation exposure. Besides SPECT-guided CT all technical possibilities for dose reduction should be exhausted.
    Der Radiologe 06/2012; 52(7):608-14. · 0.41 Impact Factor
Show more